Herbert L. DuPont
Affiliations: | Epidemiology & Disease Control | The University of Texas School of Public Health |
Area:
Epidemiology, Public HealthGoogle:
"Herbert DuPont"Cross-listing: PHTree
Children
Sign in to add trainee| Frances I. Abraham | grad student | 2006 | The University of Texas School of Public Health |
| Sumesh Kachroo | grad student | 2008 | The University of Texas School of Public Health |
| Parvathy Nair | grad student | 2008 | The University of Texas School of Public Health |
| Kirsten M. Raines | grad student | 2012 | The University of Texas School of Public Health |
| Vineetkumar Kharat | grad student | 2013 | The University of Texas School of Public Health |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chey WD, Shah ED, DuPont HL. (2020) Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review. Therapeutic Advances in Gastroenterology. 13: 1756284819897531 |
| DuPont HL, Jiang ZD, DuPont AW, et al. (2020) Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota Transplantation. Digestive Diseases and Sciences |
| Ali H, Ma W, Khurana S, et al. (2020) Safety and efficacy of fecal microbiota transplantation (FMT) in the management of recurrent clostridioides difficile infection (rCDI) in cancer patients. Journal of Clinical Oncology. 38: e24048-e24048 |
| Wang Y, Ma W, Abu-Sbeih H, et al. (2020) Fecal microbiota transplantation (FMT) for immune checkpoint inhibitor induced–colitis (IMC) refractory to immunosuppressive therapy. Journal of Clinical Oncology. 38: 3067-3067 |
| Bamidele O, Jiang ZD, Dupont H. (2018) Occurrence of putative virulence-related genes, aatA, aggR and aaiC, of Enteroaggregative Escherichia coli (EAEC) among adults with travelers' diarrhea acquired in Guatemala and Mexico. Microbial Pathogenesis. 128: 97-99 |
| Lindsay L, DuPont HL, Moe CL, et al. (2018) Estimating the incidence of norovirus acute gastroenteritis among US and European international travelers to areas of moderate to high risk of traveler's diarrhea: a prospective cohort study protocol. Bmc Infectious Diseases. 18: 605 |
| Steffen R, Jiang ZD, Gracias Garcia ML, et al. (2018) Rifamycin SV-MMX® for treatment of travelers' diarrhea: equally effective as ciprofloxacin and not associated with the acquisition of multi-drug resistant bacteria. Journal of Travel Medicine |
| Zhu Q, Dupont CL, Jones MB, et al. (2018) Visualization-assisted binning of metagenome assemblies reveals potential new pathogenic profiles in idiopathic travelers' diarrhea. Microbiome. 6: 201 |
| Jiang ZD, Jenq RR, Ajami NJ, et al. (2018) Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial. Plos One. 13: e0205064 |
| Dogan B, Belcher-Timme HF, Dogan EI, et al. (2018) Evaluation of Escherichia coli pathotypes associated with Irritable Bowel Syndrome. Fems Microbiology Letters |